van den Akker Emile, Ano Sabine, Shih Hsiu-Ming, Wang Ling-Chi, Pironin Martine, Palvimo Jorma J, Kotaja Noora, Kirsh Olivier, Dejean Anne, Ghysdael Jacques
Institut Curie, CNRS UMR 146, Orsay, France.
J Biol Chem. 2005 Nov 11;280(45):38035-46. doi: 10.1074/jbc.M502938200. Epub 2005 Sep 7.
FLI-1 is a transcription factor of the ETS family that is involved in several developmental processes and that becomes oncogenic when overexpressed or mutated. As the functional regulators of FLI-1 are largely unknown, we performed a yeast two-hybrid screen with FLI-1 and identified the SUMO E3 ligase PIASxalpha/ARIP3 as a novel in vitro and in vivo binding partner of FLI-1. This interaction involved the ETS domain of FLI-1 and required the integrity of the SAP domain of PIASxalpha/ARIP3. SUMO-1 and Ubc9, the ubiquitin carrier protein component in the sumoylation pathway, were also identified as interactors of FLI-1. Both PIASxalpha/ARIP3 and the closely related PIASxbeta isoform specifically enhanced sumoylation of FLI-1 at Lys(67), located in its N-terminal activation domain. PIASxalpha/ARIP3 relocalized the normally nuclear but diffusely distributed FLI-1 protein to PIASxalpha nuclear bodies and repressed FLI-1 transcriptional activation as assessed using different ETS-binding site-dependent promoters and different cell systems. PIASxalpha repressive activity was independent of sumoylation and did not result from inhibition of FLI-1 DNA-binding activity. Analysis of the properties of a series of ARIP3 mutants showed that the repressive properties of PIASxalpha/ARIP3 require its physical interaction with FLI-1, identifying PIASxalpha as a novel corepressor of FLI-1.
FLI-1是ETS家族的一种转录因子,参与多种发育过程,在过表达或发生突变时具有致癌性。由于FLI-1的功能调节因子大多未知,我们用FLI-1进行了酵母双杂交筛选,鉴定出SUMO E3连接酶PIASxalpha/ARIP3是FLI-1新的体外和体内结合伴侣。这种相互作用涉及FLI-1的ETS结构域,并且需要PIASxalpha/ARIP3的SAP结构域保持完整。SUMO-1和泛素载体蛋白组分Ubc9,即SUMO化途径中的泛素载体蛋白,也被鉴定为FLI-1的相互作用分子。PIASxalpha/ARIP3和密切相关的PIASxbeta异构体均特异性增强了位于FLI-1 N端激活域的Lys(67)处的FLI-1 SUMO化。PIASxalpha/ARIP3使通常定位于细胞核但呈弥散分布的FLI-1蛋白重新定位于PIASxalpha核体,并抑制FLI-1转录激活,这是使用不同的ETS结合位点依赖性启动子和不同细胞系统评估得出的结果。PIASxalpha的抑制活性独立于SUMO化,并非由抑制FLI-1 DNA结合活性所致。对一系列ARIP3突变体特性的分析表明,PIASxalpha/ARIP3的抑制特性需要其与FLI-1进行物理相互作用,从而将PIASxalpha鉴定为FLI-1的新型共抑制因子。